Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 18/20 | 0.59 |
| ▸ | NPY1R | P25929 | 11/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.59 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21481072 | 1.00 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RQRFPR | |
| SCHEMBL31019151 | 0.96 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RQRFPR | |
| SCHEMBL29794245 | 0.94 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RQRFPR | |
| SCHEMBL30090470 | 0.94 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15092950 | 0.93 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15092953 | 0.93 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29794248 | 0.93 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RQRFPR | |
| SCHEMBL31257079 | 0.91 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29590830 | 0.90 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2RQRFPR | |
| SCHEMBL30495709 | 0.90 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RQRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748239-A1 | EMULSIFIED NUTRITIONAL COMPOSITION | Otsuka Pharmaceutical Factory, Inc. (JP) | 2026-05-27 | — | — | EP | disclosed |
| CN-122011098-A | Bullfrog protein peptide and preparation method and application thereof | 集美大学 | 2026-05-12 | — | — | CN | disclosed |
| US-12617847-B2 | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12569532-B2 | Brain function regulating agent, and food or beverage product containing same | NITTA GELATIN INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12409209-B2 | Biological function regulating agent, epidermal metabolism promoting agent, fat accumulation inhibiting agent, fat decomposition promoting agent, adiponectin production promoting agent, functional food, cosmetic product, and method for producing biological function regulating agent | NITTA GELATIN INC. (JP) | 2025-09-09 | — | — | US | disclosed |
| CN-113164769-B | Brain function regulator | 新田明胶株式会社 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025018406-A1 | EMULSIFIED NUTRITIONAL COMPOSITION | 株式会社大塚製薬工場 | 2025-01-23 | — | — | WO | disclosed |
| CN-118813743-A | Method for preparing fishbone active polypeptide by enzymolysis of immobilized enzyme | 青岛益和兴食品有限公司 | 2024-10-22 | — | — | CN | disclosed |
| US-20240342289-A1 | LEAKAGE INHIBITING AGENT FOR LOCAL INJECTION PREPARATION, LOCAL INJECTION PREPARATION INCLUDING THE SAME, AND METHOD FOR PRODUCING LOCAL INJECTION PREPARATION | NITTA GELATIN INC. (JP) | 2024-10-17 | — | — | US | disclosed |
| CN-118754932-A | Preparation method of functional peptide with xanthine oxidase inhibition effect and high F value oligopeptide | 农业农村部规划设计研究院 | 2024-10-11 | — | — | CN | disclosed |
| CN-114891850-A | Preparation method of plant protein zymolyte with interfacial activity and oxidation resistance | 山东农业大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-114794445-A | Simple and efficient method for preparing salty peptide by using wheat protein | 河南省农业科学院农副产品加工研究中心 | 2022-07-29 | — | — | CN | disclosed |
| CN-114736946-A | Preparation method and application of marine fish oligopeptide with functions of resisting fatigue and reducing uric acid | 广东海洋大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-114717071-A | Preparation device and preparation method of special active polypeptide yellow wine | 山东百脉泉酒业股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220193180-A1 | AGING PROGRESSION SUPPRESSING AGENT, AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME | NITTA GELATIN INC. (JP) | 2022-06-23 | — | — | US | disclosed |
| US-20220187308-A1 | ION CONCENTRATION-DEPENDENT BINDING MOLECULE LIBRARY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-06-16 | — | — | US | disclosed |
| CN-111440835-B | Method for extracting active peptide from low-value marine organism leftovers | 荣成海的故事调味食品有限公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-114277076-A | Method for directionally and moderately hydrolyzing bovine colostrum by using compound enzyme | 江南大学 | 2022-04-05 | — | — | CN | disclosed |
| US-20220047667-A1 | BRAIN FUNCTION REGULATING AGENT, AND FOOD OR BEVERAGE PRODUCT CONTAINING SAME | NITTA GETAIN INC. (JP) | 2022-02-17 | — | — | US | disclosed |
| CN-113736766-B | Collagen hydrolase and its coding gene, preparation method and use | 中国农业科学院农产品加工研究所 | 2022-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569532-B2 | Brain function regulating agent, and food or beverage product containing same | PYGB, CASP10, BDNF | NPY4R 166/4885NPY1R 43/4885NPY5R 122/4885 |
| US-12617847-B2 | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly | CD69, CD47, NFATC1 | NPY4R 2193/4885NPY1R 1792/4885NPY5R 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.